[go: up one dir, main page]

DE69811643D1 - Mischung primärer fettsäuren aus zuckerrohrwachs - Google Patents

Mischung primärer fettsäuren aus zuckerrohrwachs

Info

Publication number
DE69811643D1
DE69811643D1 DE69811643T DE69811643T DE69811643D1 DE 69811643 D1 DE69811643 D1 DE 69811643D1 DE 69811643 T DE69811643 T DE 69811643T DE 69811643 T DE69811643 T DE 69811643T DE 69811643 D1 DE69811643 D1 DE 69811643D1
Authority
DE
Germany
Prior art keywords
mixture
fatty acids
sugar cane
cane wax
primary fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69811643T
Other languages
English (en)
Other versions
DE69811643T2 (de
Inventor
Bravo Luis Gonzales
Delange David Marrero
Granja Abilio Laguna
Ferreiro Rosa Maria Mas
Lourdes Arruzazabala Valman De
Quintana Daysi Carbajal
Medina Mirian Cora
Soto Del Valle Robert Menendez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Dalmer SA
Original Assignee
Laboratorios Dalmer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Dalmer SA filed Critical Laboratorios Dalmer SA
Application granted granted Critical
Publication of DE69811643D1 publication Critical patent/DE69811643D1/de
Publication of DE69811643T2 publication Critical patent/DE69811643T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DE69811643T 1997-04-02 1998-04-01 Mischung primärer fettsäuren aus zuckerrohrwachs Expired - Lifetime DE69811643T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU1997035A CU22723A1 (es) 1997-04-02 1997-04-02 Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
PCT/IB1998/000870 WO1998043631A1 (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids obtained from sugar cane wax

Publications (2)

Publication Number Publication Date
DE69811643D1 true DE69811643D1 (de) 2003-04-03
DE69811643T2 DE69811643T2 (de) 2003-12-24

Family

ID=5459247

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811643T Expired - Lifetime DE69811643T2 (de) 1997-04-02 1998-04-01 Mischung primärer fettsäuren aus zuckerrohrwachs

Country Status (19)

Country Link
US (1) US6486205B2 (de)
EP (1) EP0969827B1 (de)
JP (2) JP4907750B2 (de)
CN (1) CN1230158C (de)
AR (1) AR016054A1 (de)
AT (1) ATE233087T1 (de)
AU (1) AU732045B2 (de)
BR (1) BR9808470A (de)
CA (1) CA2285242C (de)
CO (1) CO4940484A1 (de)
CU (1) CU22723A1 (de)
DE (1) DE69811643T2 (de)
DK (1) DK0969827T3 (de)
ES (1) ES2192769T3 (de)
MY (1) MY120318A (de)
PT (1) PT969827E (de)
RU (1) RU2217130C2 (de)
WO (1) WO1998043631A1 (de)
ZA (1) ZA982744B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4666705B2 (ja) * 1999-12-07 2011-04-06 三井製糖株式会社 消化管潰瘍予防剤または改善剤
US20030203854A1 (en) * 2002-04-23 2003-10-30 Ivo Pischel Composition for effecting serum cholesterol levels
EP1515714B1 (de) * 2002-06-17 2009-08-12 Medestea Research & Production S.p.A. Langkettige ungesättigte sauerstoffhaltige verbindungen und deren verwendung im therapeutischen, kosmetischen und diätetischen bereich
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
US20060013842A1 (en) * 2004-07-15 2006-01-19 Matkin John R Natural mixture of long-chain fatty alcohols and long-chain fatty acids, its obtension from animal and vegetable waxes and its nutraceutical uses
US7542034B2 (en) * 2004-09-23 2009-06-02 Conversion Works, Inc. System and method for processing video images
KR100723950B1 (ko) * 2005-01-04 2007-05-31 주식회사 하이폭시 벼과 식물 추출물을 포함하는 허혈성 질환 및 퇴행성뇌질환의 예방 및 치료를 위한 조성물
KR100685681B1 (ko) * 2005-07-26 2007-02-26 전북대학교산학협력단 수수에서 폴리코사놀 또는 옥타코사놀 함량이 높은긴사슬지방을 제조하는 방법
BRPI0606132A2 (pt) * 2005-10-12 2009-06-02 Sicor Inc formas cristalinas de docetaxel e processos para seu preparo
US20070295326A1 (en) * 2006-06-07 2007-12-27 Rafael Almagro Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters
WO2008103926A1 (en) * 2007-02-22 2008-08-28 Innlabs, Llc Vitamin c preparation
DE102010052789A1 (de) * 2010-11-27 2012-05-31 Wachs-Chemie Elsteraue E.K. Herstellung und Reinigung von PC-Wachs und deren technische Anwendungen
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
KR102429853B1 (ko) * 2017-11-30 2022-08-05 (주)아모레퍼시픽 천연 왁스를 이용한 지방산 조성물 제조방법 및 그에 따라 제조된 지방산 조성물
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007329A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
CU24638B1 (es) * 2020-02-03 2023-01-16 Centro Nac De Investigaciones Cientificas Suspensión oral con efecto antiulceroso y quimioprotector sobre el cáncer de colon
CU24732B1 (es) * 2021-07-13 2025-02-07 Centro Nac De Investigaciones Cientificas Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5160207A (en) * 1974-11-22 1976-05-26 Dai Ichi Kogyo Seiyaku Co Ltd Shibosanto kokyuarukooruno bunriho
JPH0610146B2 (ja) * 1985-10-12 1994-02-09 住友精化株式会社 直鎖第1級脂肪族高級アルコ−ルの抽出法
CA2044162A1 (fr) * 1989-10-13 1991-04-14 Jacques Borg Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophes et cytoprotectrices, et compositions pharmaceutiques les contenant
CU22225A1 (es) * 1990-11-30 1995-01-31 Cent Nac Investig Scient Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
JPH06122892A (ja) * 1992-10-09 1994-05-06 Nippon Petrochem Co Ltd 粗ワックスの製造方法
CU22412A1 (es) * 1993-11-09 1996-01-31 Dalmer Lab Sa Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
JP2804445B2 (ja) * 1994-11-30 1998-09-24 ラボラトリオス ダルマー ソシエダッド アノニマ 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
AUPO605097A0 (en) * 1997-04-07 1997-05-01 James Cook University Of North Queensland Food grade wax and process for preparing same

Also Published As

Publication number Publication date
US6486205B2 (en) 2002-11-26
JP4907750B2 (ja) 2012-04-04
CU22723A1 (es) 2002-02-28
CN1230158C (zh) 2005-12-07
US20020058705A1 (en) 2002-05-16
ATE233087T1 (de) 2003-03-15
JP2001518092A (ja) 2001-10-09
ZA982744B (en) 1998-10-08
PT969827E (pt) 2003-07-31
ES2192769T3 (es) 2003-10-16
AR016054A1 (es) 2001-06-20
CN1258218A (zh) 2000-06-28
MY120318A (en) 2005-10-31
EP0969827B1 (de) 2003-02-26
JP2012067119A (ja) 2012-04-05
RU2217130C2 (ru) 2003-11-27
AU7349498A (en) 1998-10-22
WO1998043631A1 (en) 1998-10-08
BR9808470A (pt) 2000-05-23
EP0969827A1 (de) 2000-01-12
CA2285242A1 (en) 1998-10-08
CO4940484A1 (es) 2000-07-24
AU732045B2 (en) 2001-04-12
CA2285242C (en) 2008-12-16
HK1029054A1 (en) 2001-03-23
DK0969827T3 (da) 2003-06-16
DE69811643T2 (de) 2003-12-24

Similar Documents

Publication Publication Date Title
DE69811643D1 (de) Mischung primärer fettsäuren aus zuckerrohrwachs
ATE255819T1 (de) Zusammensetzungen von süssigkeiten
NO940288D0 (no) Formuleringer inneholdende umettede fettsyrer
NO975035D0 (no) Fettsyreestere som bioaktive forbindelser
FI963867A7 (fi) Rasvahappoestereiden käyttö bioadhesiivisina aineina
NO992403L (no) Mikrokapsler av umettede fettsyrer eller fettsyreforbindelser eller blandinger av fettsyrer og/eller fettsyreforbindelser
DE122011100027I1 (de) Wassrige suspension von 9-hydroxyrisperidon-fettsaureester.
ID22218A (id) Senyawa-senyawa penghambat sekresi asam lambung
DE69818586D1 (de) Emulgierende Zusammensetzung aus Polyglycosiden und Fettalkohol
BR9608852A (pt) Composição de limpeza que contém agentes tensoativos de amida de ácidos graxos poliidroxi
DE69818500D1 (de) Herstellung von estern
EP0986296A4 (de) Fettsäureelongase
DE59501040D1 (de) Quaternierte Triethanolaminfettsäureester
FI972569A7 (fi) Triglyseridiöljyjen fraktiointi
EE03900B1 (et) Toiduhappe tootmine
DK0889873T3 (da) Fremgangsmåde til fremstilling af alkoxylerede fedtsyrealkylestere
DE69818490D1 (de) Herstellung von zuckerrohr
DE59810616D1 (de) Verfahren zur Herstellung von Saccharosefettsäureestern
BR9602897A (pt) Composição de barra de sab o
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
FI965214L (fi) Fusidihappotablettien valmistus
ZA981668B (en) Presentation of fatty acids
DE59803990D1 (de) Verwendung von fettsäurepolyglycolestersulfaten
DK0889872T3 (da) Fremgangsmåde til fremstilling af alkoxylerede fedtsyrealkylestere
DK0931051T3 (da) Fremgangsmåde til fremstilling af fedtsyreestere

Legal Events

Date Code Title Description
8364 No opposition during term of opposition